Participant demographics
| Variable | Frequency (total n=26) | |
| Recruitment site | Dermatology clinics | 17 |
| Word of mouth/social media platforms | 9 | |
| Age | Mean (SD) | 33.8 (13.6) |
| Gender | Male | 12 |
| Female | 14 | |
| Race | Chinese | 21 |
| Malay | 3 | |
| Indian | 1 | |
| Caucasian | 0 | |
| Other | 1 | |
| Education | Primary school | 1 |
| Secondary school | 3 | |
| Junior college/polytechnic/institute of technical education | 8 | |
| Bachelor’s degree | 13 | |
| Master’s/doctorate | 1 | |
| Diagnosis | Eczema | 23 |
| Psoriasis | 1 | |
| Cheilitis | 1 | |
| Prolonged drug hypersensitivity syndrome | 1 | |
| Duration of disease (years) | Mean (SD) | 13.4 (9.99) |
| Highest potency TCS | Class 1 (least potent) | 3 |
| Class 2 | 0 | |
| Class 3 | 2 | |
| Class 4 | 11 | |
| Class 5 | 6 | |
| Class 6 | 1 | |
| Class 7 (most potent) | 1 | |
| Unsure | 2 | |
| Duration of TCS use (years) | Mean (SD) | 9.34 (8.48) |
| TOPICOP (male) | Mean (SD) | 45.8 (17.8) |
| TOPICOP (female) | Mean (SD) | 56.0 (8.4) |
TCS, topical corticosteroid; TOPICOP, topical corticophobia.